Loading...
The Financial Express

WHO halts trial of malaria drug hydroxychloroquine in COVID-19 patients

| Updated: June 22, 2020 21:58:20


A pharmacist displays a box of Hydroxychloroquine at the CHR Centre Hospitalier Regional de la Citadelle Hospital amid the coronavirus disease (COVID-19) in Liege, Belgium, June 16, 2020. Reuters A pharmacist displays a box of Hydroxychloroquine at the CHR Centre Hospitalier Regional de la Citadelle Hospital amid the coronavirus disease (COVID-19) in Liege, Belgium, June 16, 2020. Reuters

The World Health Organisation said on Wednesday that testing of the malaria drug hydroxychloroquine in its large multi-country trial of treatments for COVID-19 patients had been halted after results from other trials showed no benefit, reports Reuters.

"The hydroxychloroquine arm of the SOLIDARITY trial has been stopped," WHO expert Ana Maria Henao-Restrepo told a news briefing.

Share if you like